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ABSTRACT
Objectives: To investigate for trends in sex-related
differences in the invasive diagnostic–therapeutic
cascade in a population of patients with acute coronary
syndromes (ACS).
Design: A nationwide cohort study.
Setting: Administrative and clinical registries covering all
hospitalisations, invasive cardiac procedures and deaths
in the Danish population of 5.6 million inhabitants.
Participants: We included 52 565 patients aged
30–90 years who were hospitalised with a first ACS from
January 2005 to November 2011. Follow-up was 60 days
from the day of index admission.
Main outcome measures: Diagnostic coronary
angiography, percutaneous coronary intervention or
coronary artery bypass within 60 days of index
admission.
Results: Women constituted 36%, were older, had more
comorbidity and were less likely to be admitted to a
hospital with cardiac catheterisation facilities than men.
Mortality rates were similar for both sexes. Diagnostic
coronary angiography was performed less frequently on
women compared with men, both within 1 day (31% vs
42%; p<0.001) and within 60 days (67% vs 80%;
p<0.001), yielding adjusted female–male HRs of 0.83
(0.79–0.87) and 0.86 (0.84–0.89), respectively.Among
the 39 677 patients undergoing coronary angiography,
non-obstructive coronary artery disease was more
frequent among women than men (22% vs 9%;
p<0.001). Women were less likely to undergo
percutaneous coronary intervention (58% vs 72%;
p<0.001) and coronary artery bypass (6% vs 11%,
p<0.001) within 60 days than men, yielding adjusted HRs
of 0.96 (0.92–0.99) and 0.81 (0.74–0.89), respectively.
The sex-related differences were not attenuated over time
for any of the invasive cardiac procedures (p values for
trend >0.05).
Conclusions: In this nationwide study, men were more
likely to undergo an invasive approach than women when
hospitalised with a first ACS—a difference persisting
from 2005 to 2011. Future studies should focus on the
potential mechanisms behind this differential treatment.
INTRODUCTION
Despite extensive historical knowledge of sex-
related differences in treatment and progno-
sis of patients with an acute presentation of
ischaemic heart disease,1–3 contemporary
empirical evidence supports that men are
still more likely to receive diagnostic coron-
ary angiography (DCA) and subsequent
revascularisation than women, including
recent results on large populations of
patients with acute coronary syndrome
(ACS).4 5 The underlying reasons for this dis-
parity are poorly elucidated and difﬁcult to
investigate partly due to sex-related differ-
ences in clinical presentation, risk factors
and comorbidity.6 Previous studies did not
suggest any narrowing of sex-related differ-
ences in DCA or reperfusion therapy
between 1999 and 2008.7–9 However, the
context of these ﬁndings has changed in
recent years. In Denmark, several steps have
been taken to help ensure equal access for
all cardiac patients to relevant healthcare ser-
vices. First, in 2008–2009, the Danish
National Health and Medicines Authority
implemented national fast-track protocols for
Strengths and limitations of this study
▪ Nationwide unselected cohort of 52 565 patients
with extensive information on demographics,
out-hospital medication and comorbidities.
▪ Use of validated data from the Danish registries
including detailed information on invasive
cardiac procedures.
▪ Potential unmeasured confounding due to lack of
core clinical data.
▪ Inability to discriminate between ST segment ele-
vation and non-ST segment elevation myocardial
infarction.
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patients presenting with clinically stable non-ST segment
elevation ACS (NSTE-ACS) aiming to reduce waiting
times for DCA to 72 h. Second, extensive prehospital
ﬁeld-triaging using ECG telemedicine has been grad-
ually implemented in order to identify patients with ST
segment elevation myocardial infarction (STEMI) in the
ambulance enabling swift transportation to invasive
heart centres. Finally, the Danish Heart Foundation ran
a campaign focusing on public awareness of sex-related
differences in presentation and treatment of cardiovas-
cular diseases in 2007–2012. The campaign included
advertisement on multiple media platforms using
Danish female celebrities as leading ﬁgures. Also, a total
of €2.14 million were allocated to 15 national research
projects concerning women and cardiovascular disease.
These national initiatives may have had a profound
effect ideally offsetting any disparities in the invasive
diagnostic–therapeutic cascade. Thus, we sought to
investigate for trends in sex-related differences in the
invasive diagnostic–therapeutic cascade using a contem-
porary population of patients with ACS.
METHODS
Design and data collection
We performed a nationwide register-based cohort study.
All 5.6 million citizens of Denmark are covered by pub-
licly ﬁnanced national health insurance ensuring free
access to healthcare services at all times. Each resident
has a unique personal civil registration number enabling
linkage of administrative healthcare data between
nationwide registries. The Danish National Patient
Registry holds information on all admissions to Danish
hospitals since 1978.10 Each admission is registered by
one primary diagnosis and, if appropriate, one or more
secondary diagnoses in accordance with the
International Classiﬁcation of Diseases—before 1994 the
8th revision (ICD-8) and since 1994 the 10th revision
(ICD-10). The primary diagnosis is assigned by the treat-
ing physician at discharge and describes the main
reason for diagnostic investigation and treatment during
a hospitalisation, while secondary diagnoses indicate
additional comorbidity. The diagnosis of acute myocar-
dial infarction (AMI) in the Danish National Patient
Registry has been validated, showing sensitivity, speciﬁ-
city and a positive predictive value of 90–95%.11 12 The
overall positive predictive value for ACS was 80%. We col-
lected data on invasive cardiac procedures from the
Danish Heart Registry containing registration on all
DCAs, percutaneous coronary interventions (PCI) and
coronary artery bypass graftings (CABG) since the year
2000.13 These data have been validated previously.14
Information on preadmission medication consumption
was obtained from the Danish National Prescription
Registry holding data on all redeemed prescriptions
according to the Anatomical Therapeutic Chemical clas-
siﬁcation. Owing to partial reimbursement of drug
expenses by the Danish healthcare system, the
pharmacies are required to register all disclosed pre-
scriptions to ensure accurate registration.15 We obtained
date and cause of death from the Danish Register of
Causes of Death.16 Patient-level data on emigration,
income, level of education, cohabitation status and dis-
tance to hospitals with cardiac catheterisation facilities
were collected from Statistics Denmark who also per-
formed all distance calculations using GIS
(Geographical Information System) software. All unique
identiﬁers were encrypted and data were kept and ana-
lysed on a secure server at Statistics Denmark.
Study cohort
We included all patients hospitalised with ACS (ICD-10
codes: I21 and I200) in Denmark from 1 January 2005
to 2 November 2011. Patients with a previous hospital
admission for AMI (ICD-8 code 410; ICD-10 code I21)
since 1978 or unstable angina pectoris (UAP; ICD-10
code I200) since 1995 were excluded to prevent poten-
tial misclassiﬁcation due to an unknown predictive value
of recurrent diagnoses of ACS. We excluded patients dis-
charged on the day of admission to ensure that sufﬁ-
cient time to collect consecutive cardiac biomarkers and
perform ECG monitoring necessary for establishing the
diagnosis was available. Patients who died on the day of
admission were also excluded as they were considered
ineligible for an invasive approach. Finally, we restricted
the cohort to include only patients aged 30–90 years.
The aetiology of ACS in patients <30 years is heteroge-
neous and patients >90 years are often considered frail
by physicians making them ineligible for DCA.17
Setting
The Danish national guidelines for treatment of patients
with ACS follow the guidelines of the European Society
of Cardiology.18 19 Patients with ACS were referred to
invasive heart centres from local hospitals or through
well-developed emergency medical services depending
on the clinical presentation. Only a minor group was
self-directed or referred to emergency departments
from their general practitioner. The number of patients
undergoing intravenous thrombolysis is negligible in
Denmark. A total of ﬁve invasive heart centres with facil-
ities for performing DCA, PCI and CABG, and eight sat-
ellite centres with cardiac catheterisation facilities were
operational during the study period.
Outcome measures
Invasive examination with DCA within 60 days of index
admission was investigated for the entire study cohort.
This observation period has been shown to capture the
majority of DCA performed following ACS.4 Cardiac
catheterisations performed within 1 and 3 days corre-
sponding to early and delayed procedures were also
assessed. Revascularisation with PCI or CABG within
60 days of index admission was investigated as composite
and separate outcomes in the subgroup of patients who
underwent DCA.
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Explanatory variables
Demographic variables
Each patient’s age was categorised into 10-year intervals
and included in the analyses as a categorical variable.
Socioeconomic status was assessed by annual net family
income after taxes calculated separately for patients ≤65
and >65 years of age in order to account for any
changes following retirement, highest achieved educa-
tional level and cohabitation status.20 21 Annual net
family income was divided into tertiles of low (≤65 years:
<€34 639/>65 years: <€27 132), medium (€34 639–
€57 633/€27 132–€44 512) or high (>€57 633/>€44 512)
income. Highest achieved educational level was divided
into three groups according to duration of training:
short (a maximum of 9 years of school), medium
(grammar school or vocational training) or long (uni-
versity degree). The shortest distance needed to travel
by road in order to reach a hospital with cardiac cath-
eterisation facilities was calculated for each patient using
range in kilometres from home address as of 1 January
in the year of admission.
Comorbidity
Comorbidity was deﬁned using primary and secondary
diagnoses from up to 1 year prior to, until and including
the index admission. Diagnoses of heart failure, cardio-
genic shock, dysrhythmia and pulmonary oedema indi-
cated the severity of heart disease. Diagnoses of
malignancy, diabetes with complications, cerebrovascular
disease, as well as acute and chronic renal failure were
used to assess additional comorbidity. We used the
ICD-10 coding in accordance with the work of So et al,22
who validated the ICD-10 codes based on the Ontario
MI mortality predictive rule23 for the above comorbid-
ities as predictors of death within 30 days and 1 year of
AMI. Chronic obstructive pulmonary disease was
included independently in the model (ICD-10; J40-44,
J47) as a proxy for further chronic comorbidity. Prior
revascularisation within 3 years of the index event was
included in the analyses, as this may have inﬂuenced the
decision to initiate invasive examination.
Hospital transfers
Transfer of patients between hospitals was identiﬁed
using an algorithm that combined unique hospital iden-
tiﬁers, dates of admission and dates of discharge into
one total index hospitalisation provided that dates were
overlapping.
Extent of coronary artery disease
The extent of coronary artery disease was assessed by
the number of vessels affected and categorised into
four groups: no signiﬁcant stenoses, one-vessel disease,
two-vessel disease and three-vessel disease. The ﬁrst
group included ﬁndings of normal coronary arteries or
diffuse non-obstructive atherosclerosis, while the latter
two groups also included patients with left main
coronary artery disease. A signiﬁcant lesion was deﬁned
as at least 50% stenosis in a major epicardial vessel or
CABG.
Statistical analysis
Continuous data are presented as median (IQR). Discrete
data are presented as percentages. We used a non-
parametric Mann-Whitney U test to test for differences in
continuous variables. χ2 Test was used to compare discrete
data and Fisher’s exact test was used if the expected
number of observations in a group was below 5.
We calculated and plotted cumulative incidences for
men and women using a competing risks model with all-
cause mortality as a competing risk.24 Sex-related differ-
ences in outcomes were estimated using univariable and
multivariable proportional hazards Cox regression models
applying robust estimation under the assumption that
observations were correlated within individual hospitals.
We applied a basic Cox regression model with sequential
adjustments for age, year of admission, prior revascularisa-
tion, concomitant heart disease (cardiac arrhythmia, heart
failure, pulmonary oedema and cardiogenic shock) and
concomitant comorbidity (cancer, chronic obstructive pul-
monary disease (COPD), cerebrovascular disease, diabetes
with complications, acute renal failure and chronic renal
failure). In the analyses on DCA, we performed additional
adjustments for demographic characteristics including dis-
tance from place of residence to the nearest hospital with
cardiac catheterisation facilities, income, level of education
and cohabitation status. Similarly, we adjusted for extent of
coronary artery disease in the analyses of revascularisation.
Motivated by prior ﬁndings that severity of coronary artery
disease as assessed during cardiac catheterisation may
affect the use of reperfusion therapy differently in women
and men,25 we conducted an interaction analysis between
sex and extent of coronary disease. Missing data were
excluded from the Cox regression models, but sensitivity
analyses including missing data as a separate level were
performed to assess the inﬂuence on our estimates (see
online supplementary material). Temporal trends in sex-
related differences were estimated in the fully adjusted
Cox regression models by including an interaction term
between sex and year of admission in the model and using
a log-likelihood ratio test to test for signiﬁcance.
Model assumptions—interactions, non-informative
censoring and proportional hazards—were found valid
unless otherwise indicated. All hypothesis tests had a
two-sided signiﬁcance level of 0.05. Analyses were per-
formed using Stata Statistics/Data analysis, MP V.13.0
(StataCorp, Texas, USA).
RESULTS
In Denmark, a total of 59 031 patients were admitted
with a ﬁrst ACS from 1 January 2005 to 2 November
2011. In total 1035 patients died on the day of admis-
sion, 1953 patients were <30 or >90 years of age and
3478 patients were discharged on the day of
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hospitalisation. Adjusted 60-day mortality was similar
between women and men (see supplementary material).
Baseline characteristics
Table 1 lists the baseline characteristics of women and
men as well as the entire study population. Women con-
stituted 36% of the study population. On index admis-
sion, women were on average 8 years older and
presented with more comorbidity—including cardiac
arrhythmias, heart failure, COPD, neoplastic disorders,
cerebrovascular disease and diabetes with complications
—than did men. Accordingly, a larger proportion of
women were receiving antihypertensive medication,
statins, β-blockers, aspirin and loop-diuretics prior to
admission compared with men. Men, however, had more
concomitant chronic renal failure than women. Also,
men more frequently had a history of prior revasculari-
sation compared with women. Inspite of living slightly
further from hospitals with cardiac catheterisation facil-
ities, men were more likely to be admitted directly to
such a hospital and hence to be transferred during
index admission. Finally, a higher proportion of women
lived alone and had a lower income and a shorter edu-
cation than did men.
Invasive examination
During the entire study period, a lower proportion of
women were investigated with DCA at 1 day (31% vs
42%; p<0.001), at 3 days (36% vs 49%; p<0.001) and at
60 days (67% vs 80%; p<0.001) compared with men
(table 1). The higher cumulative incidence of examin-
ation with DCA in men compared with women (ﬁgure 1A)
resulted in an unadjusted female–male HR of 0.71
(0.68–0.74) with similar results at days 0–1, days 2–3 and
the following 56 days (table 2). Sequential adjustment
for explanatory variables attenuated the HR to 0.86
(0.84–0.89) at day 60 with similar results at days 0–1,
days 2–3 and the following 56 days (table 2), suggesting
consistently lower rates of DCA in women compared
with men. When stratifying for year of admission, an
equal increase in the cumulative incidence over time for
both genders with a relatively larger increase from 2008–
2009 to 2010–2011 was demonstrated (ﬁgure 1B).
Accordingly, there was no interaction between sex and
year of admission suggesting persistent sex-related differ-
ences (ﬁgure 1B, table 2). As an additional analysis to
assess the robustness of our results, we excluded all
patients with a diagnosis of UAP (n=8474) and obtained
estimates almost identical to those described above
(see online supplementary material).
Extent of coronary artery disease
Among the 39 677 patients examined with DCA within
60 days, women were more likely than men to have no
obstructive stenoses (22% vs 9%; p<0.001), while two-
vessel and three-vessel disease were more frequent
among men (20% vs 15%; p<0.001 and 17% vs 13%;
p<0.001, respectively; table 3).
Revascularisation
Among patients examined with DCA within 60 days of
index hospitalisation, less women were revascularised
compared with men (63% vs 81%; p<0.001). This was
consistent for the use of PCI (58% vs 72%; p<0.001) and
CABG (6% vs 11%; p<0.001), respectively (table 3). The
higher cumulative incidence for revascularisation when
examined with DCA within 60 days in men compared
with women (ﬁgure 2A) yielded an unadjusted HR of
0.66 (0.64–0.69). Adjusting for explanatory variables
including the extent of coronary disease attenuated the
HR to 0.93 (0.90–0.96). Stratifying for the year of admis-
sion demonstrated an equal slight increase in the cumu-
lative incidence over time for both genders (ﬁgure 2B).
Looking at PCI and CABG separately in the fully
adjusted models, female gender was associated with a
slightly lower rate of PCI at 60 days with HR 0.96 (0.93–
0.99), on days 0–1 with HR 0.96 (0.93–0.99) and on days
2–60 with HR 0.94 (0.89–0.98). A similar estimate for
CABG at day 60 was HR 0.81 (0.74–0.89). There were no
interactions between sex and year of admission in either
model, suggesting that sex-related differences remained
(ﬁgure 2B, see online supplementary material).
A signiﬁcant interaction between the extent of coron-
ary artery disease and sex was present (p<0.001), sug-
gesting that the ﬁndings on coronary angiography
modiﬁed the association between sex and revascularisa-
tion. More speciﬁcally, the sex-related differences were
conﬁned to patients with no signiﬁcant stenosis or one-
vessel disease (ﬁgure 3) and those undergoing CABG
(data not shown).
DISCUSSION
Principal findings
In this nationwide study of patients hospitalised with a
ﬁrst ACS in 2005–2011, we found no attenuation of sex-
related differences in the invasive diagnostic–therapeutic
cascade. Women were 14% less likely than men to
undergo DCA within 60 days, a difference that was
present from the day of admission. Similar but less pro-
nounced differences were found for subsequent revascu-
larisation, but were limited to patients with no
signiﬁcant stenoses or one-vessel disease.
Study strengths and weaknesses
Our study population was comprised of a large unse-
lected cohort of patients with ACS. Inclusion of all
Danish citizens aged 30–90 years (constituting 3.2
million inhabitants in 2009) regardless of social status,
attachment to the labour market or race minimises
potential selection bias giving a nationwide perspective
of the handling of patients with ACS.
Our study had several limitations that should be con-
sidered when interpreting the ﬁndings. The study was
strictly observational. We were unable to directly
measure the implementation and effect of the national
public awareness campaign, fast-track protocols and
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prehospital triage. However, recent data suggest an
impact of the latter two on access to invasive cardiac pro-
cedures in patients with ACS.26 27 Because of the imple-
mentation of highly sensitive cardiac troponins and
endorsement of the third universal deﬁnition of myocar-
dial infarction, the composition of the ACS population
in terms of STEMI, NSTEMI, and UAP may have
changed during the study period.28 Information on core
clinical variables, such as time of onset of symptoms,
cardiac biomarkers, ECG ﬁndings or left ventricular
ejection fraction, was not available to us; neither was
information on prehospital data or out-hospital deaths.
We were unable to discriminate between STEMI and
NSTEMI, as the ICD-10 diagnoses for these subdiag-
noses have not been validated in the Danish National
Patient Register. Thus, we cannot rule out unmeasured
Table 1 Baseline characteristics
Women
n=19 056
Men
n=33 509 p Value
All
N=52 565
Demographics
Age at admission* 73 (62–81) 65 (56–75) <0.001 68 (58–78)
Low income† 6916 (36) 10 825 (32) <0.001 17 741 (34)
Short education‡ 8842 (46) 10 766 (32) <0.001 19 608 (37)
Living alone§ 10 659 (56) 11 093 (33) <0.001 21 752 (41)
Distance in kilometres to nearest
Invasive heart centre* 43 (12–77) 44 (14–79) <0.001 43 (13–78)
Hospital with cardiac catheterisation facilities* 23 (8–41) 23 (8–42) <0.001 23 (8–42)
Risk factors
Medications prior to index admission (%)
Antihypertensive medication 10 577 (56) 14 949 (45) <0.001 25 526 (49)
Statin or other lipid-lowering drug 5077 (27) 8347 (25) <0.001 13 424 (26)
β-blockers 5016 (26) 6593 (20) <0.001 11 609 (22)
Aspirin 6309 (33) 9247 (28) <0.001 15 556 (30)
Loop diuretics 3671 (19) 3676 (11) <0.001 7347 (14)
Concomitant heart disease (%)
Cardiac arrhythmia 2505 (13) 3555 (11) <0.001 6060 (12)
Heart failure 2055 (11) 2924 (9) <0.001 4979 (9)
Pulmonary oedema 156 (1) 177 (1) <0.001 333 (1)
Cardiogenic shock 103 (1) 164 (1) 0.44 267 (1)
Concomitant comorbidity (%)
Cancer 488 (3) 913 (3) 0.27 1401 (3)
COPD 1531 (8) 1519 (5) <0.001 3050 (6)
Cerebrovascular disease 1049 (6) 1398 (4) <0.001 2447 (5)
Diabetes with complications 896 (5) 1433 (4) 0.02 2329 (4)
Acute renal failure 172 (1) 358 (1) 0.07 530 (1)
Chronic renal failure 275 (1) 621 (2) <0.001 896 (2)
Prior revascularisation within 3 years of index event (%) 392 (2) 1017 (3) <0.001 1409 (3)
Index hospitalisation
Length of hospital stay* 5 (3–8) 5 (3–7) <0.001 5 (3–7)
Discharge diagnosis (%) <0.001¶
Unstable angina pectoris 3345 (18) 5129 (15) 8474 (16)
Myocardial infarction 15 711 (82) 28 380 (85) 44 091 (84)
Index admission at hospital with invasive cardiac facilities (%) 7398 (39) 14 816 (44) <0.001 22 214 (42)
Number of transfers (%) <0.001¶
None 12 830 (67) 19 745 (59) 32 575 (62)
1 4345 (23) 9935 (30) 14 280 (27)
2 or more 1881 (10) 3829 (11) 5710 (11)
Diagnostic coronary angiography (%)
Day 1 5822 (31) 14 125 (42) <0.001 19 947 (38)
Day 3 6857 (36) 16 258 (49) <0.001 23 115 (44)
Day 60 12 769 (67) 26 919 (80) <0.001 39 688 (76)
*Median (IQR).
†Defined as a yearly income after all taxes below the first tertile in the study cohort (missing=245).
‡Defined as a maximum of 9 years of school (missing=3670).
§Missing=164.
¶χ2 p Value for a 2xk table.
COPD, chronic obstructive pulmonary disease.
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confounding. Inclusion of clinical variables in future
studies would allow for a validated severity score of ACS
on presentation providing a tool to assess appropriate-
ness of DCA use between sexes. Finally, our results only
reﬂect Danish conditions in terms of geography and
healthcare services.
Interpretation
In everyday clinical practice, referral of patients pre-
senting with ACS to coronary angiography is preceded
by a complex web of decision-making. Although these
nuances are difﬁcult to capture in administrative
healthcare data, our observations have several interest-
ing aspects. The sex-related differences in rates of DCA
persisted throughout the study period with women
being 15% less likely to undergo an invasive strategy.
Similar results have previously been reported from
other ACS registries.8 9 Even among more selected
patients presenting with AMI and deemed ideal candi-
dates for coronary angiography based on clinical pres-
entation and availability of cardiac catheterisation on
admission, women were consistently less invasively
examined than men.7 This suggests that clinical vari-
ables alone cannot fully explain these disparities. Our
analyses indicated that patient-related factors such as
distance to nearest cardiac catheterisation hospital and
socioeconomic status—factors that are correlated with
access to healthcare and patient behaviour—did not
account for the differential use of DCA according to
sex. Although our ﬁndings do not bring us any closer
to understanding the nature of these sex-related differ-
ences in referral for DCA, current evidence provides
some clues. Unlike men, women presenting with
low-risk NSTE-ACS do not seem to beneﬁt from an
early invasive approach.29 As physicians tend to under-
estimate patient risk in women,8 this may prevent or
defer the use of coronary interventions. Also, women
are more likely to experience periprocedural complica-
tions such as bleedings.30 Finally, it has been reported
that sex-related differences in referral for cardiac cath-
eterisation are only present in patients with equivocal
indications for the procedure,31 suggesting either an
overuse in men or an underuse in women.
In the subgroup of patients undergoing coronary angi-
ography, non-obstructive coronary artery disease was
found in 22% of women; more than twice as frequent as
in men. This ﬁnding is consistent with the ﬁndings of
prior studies29 32 and has been attributed to sex-related
Figure 1 Cumulative incidence curves for undergoing coronary angiography within 60 days of admission with acute coronary
syndromes.
Table 2 HRs for examination with coronary angiography in women versus men
Model 1* Model 2† Model 3‡ Model 4§ Model 5¶
p Value for
interaction**
DCA at 60 days 0.71 (0.68–0.74) 0.84 (0.82–0.86) 0.83 (0.81–0.85) 0.84 (0.82–0.87) 0.86 (0.84–0.89) 0.34
Days 0–1 0.70 (0.66–0.73) 0.80 (0.77–0.83) 0.81 (0.77–0.85) 0.83 (0.79–0.87) 0.84 (0.80–0.88) 0.85
Days 2–3 0.73 (0.70–0.76) 0.86 (0.82–0.90) 0.85 (0.81–0.89) 0.86 (0.81–0.90) 0.87 (0.83–0.91) 0.67
Days 4–60 0.71 (0.68–0.74) 0.88 (0.85–0.91) 0.85 (0.82–0.88) 0.86 (0.83–0.89) 0.90 (0.87–0.93) 0.28
*Model 1: unadjusted.
†Model 2: adjustment for age group.
‡Model 3: model 2+adjustment for year of admission, prior revascularisation, cardiac arrhythmias, heart failure, pulmonary oedema,
cardiogenic shock, cancer, COPD, cerebrovascular disease, diabetes with complications, acute and chronic renal failure and distance to
nearest hospital with cardiac catheterisation facilities.
§Model 4: model 3+adjustment for use of antihypertensive medication, statin or other lipid-lowering drug, β-blockers, aspirin, and
loop-diuretics prior to index admission.
¶Model 5: model 4+adjustment for income, level of education and living alone (n=48 609).
**Log-likelihood ratio test p value for interaction between sex and year of admission using model 5.
COPD, chronic obstructive pulmonary disease; DCA, diagnostic coronary angiography.
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Table 3 Result of coronary angiography and subsequent revascularisation
Women
n=12 769
Men
n=26 919 p Value
All
N=39 688
Extent of coronary disease (%) <0.001*
No significant stenoses† 2849 (22) 2374 (9) 5223 (13)
1-vessel disease 4423 (35) 10 502 (39) 14 925 (38)
2-vessel disease 1889 (15) 5318 (20) 7207 (18)
3-vessel disease 1604 (13) 4641 (17) 6245 (16)
Missing‡ 2004 (16) 4084 (15) 6088 (15)
Revascularisation within 60 days (%)
Any 8082 (63) 21 777 (81) <0.001 29 859 (75)
PCI 7370 (58) 19 302 (72) <0.001 26 672 (67)
CABG 824 (6) 3018 (11) <0.001 3842 (10)
*χ2 p Value for a 2xk table.
†Composite of normal coronary arteries and diffuse atherosclerotic disease.
‡See online supplementary material for additional analyses.
CABG, coronary artery bypass-grafting; PCI, percutaneous coronary intervention.
Figure 2 Cumulative incidence curves for undergoing any revascularisation within 60 days of admission among patients with
acute coronary syndromes examined with coronary angiography.
Figure 3 Unadjusted and multivariable-adjusted revascularisation at 60 days in women versus men stratified by extent of
coronary artery disease. Adjusted model with adjustments for age group, year of admission, prior revascularisation, cardiac
arrhythmias, heart failure, pulmonary oedema, cardiogenic shock, cancer, chronic obstructive pulmonary disease,
cerebrovascular disease, diabetes with complications, acute and chronic renal failure.
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differences in the aetiology of MI with, for example, cor-
onary artery spasms, rupture or erosion of eccentric
plaques, microvascular disease including Takotsubo syn-
drome being more frequent in women.33 34 However,
recent data also suggest that a sex-speciﬁc diagnostic
threshold for MI using high-sensitivity troponins could
reclassify women at an increased risk of reinfarction or
death who would otherwise be missed using conven-
tional cut-off values.35 Hence, the relatively high preva-
lence of unobstructed coronary arteries in women versus
men undergoing DCA may reﬂect a differing underlying
aetiology rather than an exaggerated incorrect use of
the MI diagnosis in women.
Although women were less likely to be revascularised
than men, these differences were largely explained by
the extent of coronary artery disease in patients under-
going PCI. The remaining differences were driven by
higher rates of revascularisation in men with non-
obstructive or one-vessel disease as compared with
women, even though rates of CABG remained higher in
men. This is consistent with prior ﬁndings of higher
rates of revascularisations in men when not clinically
indicated compared with women.36 However, the lack of
core clinical variables in our analyses prevents us from
drawing any ﬁrm conclusions. Coronary angiography is
usually performed with intention to revascularise, if pos-
sible. Therefore, procedure-related factors such as vessel
size, tortuosity and potential complications would in all
likelihood explain the remaining sex-related differences
in selection for reperfusion therapy.
In conclusion, despite extensive national measures with
a shared goal of ensuring equal access to invasive cardiac
procedures, sex-related differences in the use of invasive
examination and subsequent revascularisation were still
present among patients admitted with a ﬁrst ACS with no
signs of a catch-up effect among women. Future studies
of the clinical pathways precluding the decision to
perform a cardiac catheterisation in women and men are
needed to clarify the basis of the sex-related gap in inva-
sive handling of patients with ACS. More speciﬁcally, the
questions of whether a differing invasive approach in
women and men represents a clinically appropriate strat-
egy, an overuse of cardiac catheterisation in men or an
actual underuse in women, and how this affects clinical
outcomes need to be addressed adequately.
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